Enhancing study success with advanced clinical research technologies and expert solutions for COPD trials.
COPD Trial Solutions
Effective solutions for advancing COPD research
Over 16 million people suffer from chronic obstructive pulmonary disease (COPD) in the US alone. Although preventable and treatable, this common disease causes difficulty breathing and can progressively worsen over time. Researchers are working to develop treatments to control symptoms and improve the patient's quality of life. Signant's digital solutions help researchers monitor patients and collect high-quality evidence.
Why Signant Health
- Access Real-Time Data
- Capture Informed Signatures
- Observe Real-World Behavior
- Engage with Patients
- Streamline Randomization
- Virtual Visits
-
Access Real-Time Data
Access Real-Time Data
Our Signant SmartSignals eCOA solution features ready-to-go questionnaires, including the SGRQ, EXACT-PRO, CAT, and the mMRC scale, for inclusion criteria and endpoints. The digital tool is particularly helpful in respiratory studies like COPD by giving sites and study teams access to real-time data.
-
Capture Informed Signatures
Capture Informed Signatures
Signant SmartSignals eConsent uses engaging multimedia to teach study requirements to patients and caregivers. The digital solution also ensures the various consents are completed with the correct IRB- or EC-approved form. -
Observe Real-World Behavior
Observe Real-World Behavior
Integrate eCOA with our pulse oximeter to gain insight into changes in the patient's respiration rate and blood oxygen levels. You can also integrate our Actigraph sensors and wearables to for a comprehensive understanding of the effects of the disease and treatment on the patient's every day life.
-
Engage with Patients
Engage with Patients
Our patient engagement solution is conveniently located on the same platform as our eCOA solution, providing a single touchpoint for patients to access visit schedules, medication intake instructions, study updates, and reminders.
-
Streamline Randomization
Streamline Randomization
Choose Signant’s Randomization & Trial Supply Management (RTSM) solution to efficiently handle randomization and deliver medication on time to patients around the world. -
Virtual Visits
Virtual Visits
Signant SmartSignals Telemedicine can replace in-person visits with convenient video consultations, reducing travel burdens for patients.
Comprehensive COPD experience
STUDIES
PATIENTS
COUNTRIES
SITES
Explore our COPD trial resources
Highlighted eClinical solutions for COPD research
Ready to learn more?
Discover how Signant can support your current or upcoming COPD trials.